The NAD(P)H:quinone oxidoreductase locus in human colon carcinoma HCT 116 cells resistant to mitomycin C

Cancer Research

Volumn 56, Issue 22, 1996, Pages 5253-5259

  Hu, Li Tai ^a   Stamberg, Judith ^b   Pan, Su Shu ^a,b  

^a UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE;

ALLELE; ALTERNATIVE RNA SPLICING; ARTICLE; CHROMOSOME 16; CODON; COLON CARCINOMA; DNA DAMAGE; DNA METHYLATION; DNA SEQUENCE; ENZYME ACTIVITY; EXON; GENE DELETION; GENE LOCUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION;

ANTIBIOTICS, ANTINEOPLASTIC; CHROMOSOME ABERRATIONS; COLONIC NEOPLASMS; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; EXONS; HUMANS; KARYOTYPING; MITOMYCIN; MOLECULAR WEIGHT; NAD(P)H DEHYDROGENASE (QUINONE); NEOPLASM PROTEINS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0029825631     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ernster, L., Danielson, L., and Ljunggren, M DT-diaphorase. I. Purification from the soluble fraction of rat-liver cytoplasm and properties. Biochem. Biophys. Acta, 58: 171-188, 1961.
2. Riley, R. J., and Workman, P DT-diaphorase and cancer chemotherapy. Biochem. Pharmacol., 43: 1657-1669, 1992.
3. Workman, P. Enzyme-directed bioreductive drug development revisited: a commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphorase Oncology Res., 6: 461-475, 1994.
4. 1) gene structure and induction by dioxin Biochemistry, 30: 10647-10653, 1991.
5. Li, Y., and Jaiswal, A. K. Regulation of human NAD(P)H:quinone oxidoreductase gene: role of AP1 binding site contained within human antioxidant response element J. Biol Chem., 267: 15097-15104, 1992.
6. Xie, T., Belinsky, M., Xu, Y., and Jaiswal, A. K ARE- and TRE-mediated regulation of gene expression, response to xenobiotics and antioxidants. J. Biol. Chem., 270: 6894-6900, 1995.
7. Schlager, J. J., and Powis, G. Cytosolic NAD(P)H:(quinone-acceptor)oxidoreductase in human normal and tumor tissue effects of cigarette smoking and alcohol Int. J Cancer, 45: 403-409, 1990.
8. 1) gene in tumor cells compared to normal cells of the same origin. Biochem Pharmacol., 42: 1021-1027, 1991
9. Schor, N. A., and Cornelisse, C. J. Biochemical and quantitative histochemical study of reduced pyridine nucleotide dehydrogenation by human colon carcinomas. Cancer Res., 43: 4850-4855, 1983.
10. Koudstaal, J., Makkink, B., and Overdiep, S. H. Enzyme histochemical pattern in human tumors. II. Oxidoreductases in carcinoma of the colon and the breast. Eur. J. Cancer, 11: 111-115, 1975.
11. Traver, R D., Honkoshi, T., Danenberg, K. D., Stadlbauer, T H., Danenber, P V., Ross, D., and Gilbson, N. W. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Cancer Res., 52: 797-802, 1992.
12. Eickelmann, P., Schulz, W A., Roche, D., Schmitz-Drager, B., and Sies, H. Loss of heterozygosity at the NAD(P)H:quinone oxidoreductase locus associated with increased resistance against mitomycin C in a human bladder carcinoma cell line. Biol. Chem. Hoppe-Seyler, 375: 439-445, 1994.
13. Marshall, R. S. Paterson, M. C., and Rauth, A M. Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditions Br. J Cancer, 59: 341-346, 1989.
14. Marshall, R. S., Paterson, M. C., and Rauth, A. M. Studies on the mechanism of resistance to mitomycin C and porfiromycin in a human cell strain derived from a cancer-prone individual Biochem Pharmacol., 41: 1351-1360, 1991.
15. Dulhanty, A. M., and Whitmore, G. F. Chinese hamster ovary cell lines resistant to mitomycin C under aerobic but not hypoxic conditions are deficient in DT-diaphorase Cancer Res., 51: 1860-1865, 1991.
16. Begleiter, A., Robotham, E., Lacey, G., and Leith, M. K. Increased sensitivity of quinone resistant cells to mitomycin C. Cancer Lett., 45: 173-176, 1989.
17. Pan, S., Akman, S A., Forrest, G. L., Hipsher, C., and Johnson, R The role of NAD(P)H quinone oxidoreductase in mitomycin C- and porfiromycin-resistant HCT 116 human colon-cancer cells. Cancer Chemother., 31: 23-31, 1992.
18. 1) expression and mitomycin C resistance developed by human colon cancer HCT 116 cells. Cancer Res., 55: 330-335, 1995.
19. Jaiswal, A. K., McBride, O. W., Adesnik, M., and Neben D. W Human dioxin-inducible cytosolic NAD(P)H:menadione oxidoreductase, cDNA sequence and localization of gene to chromosome 16 J Biol. Chem., 263: 13572-13578, 1988.
20. Ng, S-Y., Gunning, P., Eddy, R., Ponte, P., Leavitt, J., Shows, T., and Kekes, L. Evolution of the functional human β-actin gene and its multi-pseudogene family: conservation of noncoding regions and chromosomal dispersion of pseudogenes. Mol. Cell. Biol., 5: 2720-2732, 1985.
21. Fontana, J. A Interaction of retinoids and tamoxifen on the inhibition of human mammary carcinoma cell proliferation Exp. Cell Biol., 55: 136-144, 1987.
22. Collins, S., Gallo, R C., and Gallagher, R E. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature (Lond.), 270 347-349, 1977.
23. Horikoshi, T., Danenberg, K D., Stadlbauer, T H. W., Volkenandt, M., Luke, C C., Shea, L. C., Aigner, K., Gustavsson, B., Leichman, L., Frosomg, R., Ray, M., Gibson, N. W., Spears, C P., and Danenberg, P Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res., 52: 108-116, 1992.
24. Blin, N., and Stafford, D. W. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res., 3: 2303-2308, 1976.
25. Southern, E. M Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 98: 503-517, 1975.
26. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. Transfection of DNA into eukaryotic cells In: Current Protocols in Molecular Biology, Suppl. 14, pp. 9.1.1-9.1.9. New York Wiley and Sons, 1990.
27. Verma, R. S., and Babu, A. Human Chromosomes: Manual of Basic Techniques, pp. 4-108. New York: Pergamon Press, 1989.
28. Lichter, P., and Cremer, T. Chromosome analysis by non-isotopic in situ hybridization In: D E. Rooney and B H. Czepulkowski (eds.), Human Cytogenetics, Vol. I, pp. 157-192. New York: Oxford University Press, 1992.
29. Malkinson, A M., Siegel, D., Forrest, G. L., Gazdar, A. F., Oie, H. K., Chan, D C., Bunn, P A., Mabry, M., Dykes, D. J., Harrison, S D. Jr., and Ross, D Elevated DT-diaphorase activity and messenger RNA content in human non-small long carcinoma relationship to the response of lung tumor xenografts to mitomycin C. Cancer Res., 52: 4752-4757, 1992.
30. Fitzsimmons, S., Workman, P., Grever, M., Paull, K., Camalier, R., and Lewis, A. D. Reductase enzyme expression across the National Cancer Institute tumor cell line panel: correlation with sensitivity to mitomycin C and EO9. J. Natl. Cancer Inst., 88: 259-269, 1996.
31. Robertson, N., Stratford, I J., Houlbrook, S., Carmichael, J., and Adams, G. E. The sensitivity of human tumour cells to quinone bioreductive drugs. What role for DT-diaphorase? Biochem. Pharmacol., 44: 409-412, 1992.
32. Nishiyama, M., Saeki, S., Aogi, K., Hirabayashi, N., and Toge, T Relevance of DT-diaphorase activity to mitomycin C (MMC) efficacy on human cancer cells: differences in vitro and in vivo systems Int. J. Cancer, 53: 1013-1016, 1993.
33. 1 (DT-diaphorase) messenger RNA lacking the putative quinone substrate binding site is present in human normal and tumor tissues. Cancer Res., 55: 2542-2547, 1995.
34. Yao, K., Xanthoudadis, S., Curran, T., and O'Dwyer, P. J. Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol. Cell. Biol., 14: 5997-6003, 1994.
35. Yao, K., and O'Dwyer, P. J. Involvement of NF-κB in the induction of NAD(P)H: quinone oxidoreductase (DT-diaphorase) by hypoxia, oltipraz and mitomycin C Biochem. Pharmacol., 49: 275-282, 1995.
36. Willson, J K. V., Long, B. H., Marks, M E., Brattain, D. E., Willey, J. E., and Brattain, M. G Mitomycin C resistance in a human colon carcinoma cell line associated with cell surface protein alterations. Cancer Res., 44: 5880-5885, 1984.
37. Traver, R. D., Phillips, R. M., Gibson, N. W., and Ross, D A point mutation in both human lung and colon carcinoma cell lines leading to a loss of DT-diaphorase activity. Proc Am. Assoc Cancer Res., 36: 525, 1995.
38. 1). Proc. Am. Assoc. Cancer Res., 37: 278, 1996.